Status:
RECRUITING
Combating HIV Stigma in Healthcare Settings: A Standardized Patient Approach
Lead Sponsor:
University of Minnesota
Conditions:
Hiv
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
The goal of this study is to develop and evaluate the effectiveness of a training program to reduce intersectional stigma faced by sexual minorities and people living with HIV (PLWH) in healthcare set...
Detailed Description
Consistent data highlight the central role of stigma in limiting uptake of HIV related testing, treatment, and care. This is particularly true for gay, bisexual, and other MSM who have the lowest rate...
Eligibility Criteria
Inclusion
- Eligible facilities are those with
- formal government accreditation as a medical center (a basic tenet of all public hospitals in China); and
- possession of an accredited on-site laboratory with capacity to provide enzyme- linked immunosorbent assay testing for HIV, treponemal (e.g. Treponema pallidum particle agglutination) and non-treponemal tests (e.g. rapid plasma regain) for syphilis. Within eligible and consenting facilities, eligible providers are those who are licensed at the time of the study to practice STD care in China.
Exclusion
- None
Key Trial Info
Start Date :
May 7 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2028
Estimated Enrollment :
155 Patients enrolled
Trial Details
Trial ID
NCT06975176
Start Date
May 7 2025
End Date
October 31 2028
Last Update
July 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455